Friends of Science in Medicine
What does “anti-vaccine” really mean since the pandemic hit? Dr Gorski writes on how the meaning of the term “anti-vaccine” has changed since the pandemic. (Spoiler, it hasn’t changed much).
Many people dismiss the term “anti-vaccine” as mere reflexive labelling. … [Read more...]
The NSW ‘lockdown’ that isn’t while putting business before people: A ‘lockdown’ strategy that does not involve lockdown, a vaccine distribution policy that is dangerously inconsistent and COVID-19 testing facilities that cannot meet the demand generated by public health orders, … [Read more...]
Can we have confidence in the Therapeutic Goods Administration? There are only two TGA checks on the regulation of listed products: a small number of post-marketing surveillance reviews [1.6% of market] and the advertising complaint system. Of reviewed products 75% are … [Read more...]
TGA does ‘terrible job’ on CMS, say critics: Dr Ken Harvey, president of Friends of Science in Medicine, and Honorary Adjunct Associate Professor at Bond University, and Professor John Dwyer AO, Past President of Friends of Science in Medicine, and Emeritus … [Read more...]
Explaining the AstraZeneca blood clots: what are our risks and how do we proceed? FSM’s John Dwyer explains blood clots and the AZ vaccine – and the best way forward for Australia.
Catgut Acupuncture: “Acupuncture is … [Read more...]
Australia’s vaccine roll-out setbacks take shine off its COVID-19 success: “Unfortunately, Australia’s slow and problematic vaccine roll-out has somewhat taken the shine off our enviable reputation for managing COVID-19.”
Explaining the AstraZeneca blood clots – what are our risks and how … [Read more...]
Australia’s vaccine roll-out setbacks take shine off its COVID-19 success: Some public health experts have warned that Australia may not be able to vaccinate its entire population until the end of 2022 due to a lack of supplies. “We need to … [Read more...]
Why the complementary medicine regulatory push was shelved: The Medical Board of Australia has scaled back efforts to regulate complementary medicines – reverting to the status quo of a ‘risk based’ approach. This means that if a therapy is considered … [Read more...]
Why the complementary medicine regulatory push was shelved: The medical board of Australia have scaled back efforts to regulate complementary medicines – reverting to the status quo of a ‘risk based’ approach. This means that if a therapy is considered to … [Read more...]